Case Study: Artificial Intelligence in Early Cancer Detection

Abstract

When cancer is diagnosed at an early stage, there is a high chance of the patients surviving and the prices of treatment being affordable. Many of the currently existing conventional methods for diagnostics, such as biopsy, imaging studies, and physical examinations, are often inadequate at identifying early signs and symptoms of cancer which may consequently result in a delay in treatment and, therefore, higher mortality rates. This paper discusses the application of AI in early cancer diagnosis concerning a client who was diagnosed with early lung cancer through imaging analysis by an Artificial Intelligence machine learning programmer. In this article, the focus will be made on describing the patient path, the effectiveness of using AI systems in diagnosing the success rate of using AI technology to revolutionize cancer diagnosing processes.

Introduction

Cancer is among the major causes of death in the world and every year new cases are being recorded in millions. Cancer is a dangerous disease that has one of the highest rates of mortality; early diagnosis is always the key to survival. Some of the conventional methods of detection can even be impersonal at times and may fail to pick certain erasures in their preliminary stage. Lung, breast, skin, and colon cancers have seen AI showing potential in detecting early signs of cancer even better than ordinary techniques in the last decade.

AI systems employ algorithms upon broad amounts of data to seek out likenesses or disparities that are extremely difficult to find by human methods. One deep learning architecture – CNNs have been used in image analysis increasing the detection rates in radiology, pathology, and genomics. Here we discuss the topic of applying AI for early-stage lung cancer detection objectively proving how the application of this technology is a great benefit for patients and the community.

Patient Information

The patient is a 53-year-old male with no history of smoking and only occasional secondhand smoke. He works as a software engineer he is not very active physically, and he has no serious health issues in his family before this case. During one of the routine examination checks, later in the course of the test, the patient said let me sometimes experience a bit of chest pain and sometimes I feel pedestrian. Lung cancer was not known to run in the family, however, an occasional relative was reported to have had cancer unrelated to lung cancer.

Clinical Findings

No abnormalities were observed during the hemipatient’s physical examination, the condition being within normal limits concerning the vital signs and physical complaints with the exclusion of the mentioned chest pain. At the routine check-up for work, a chest X-ray was taken which indicated small indescrete opacities in the lat upper zone. As a result of subsequent examination of the specific category, the individual was recommended to undergo an additional CT scan. The size of the mass was approximately 0.8 cm, and such size created doubt as to whether it was malignant or not.

Timeline

Routine Health Check-Up

• Date: January 10, 2024

• Findings: Mild chest discomfort was reported; chest X-ray revealed a small mass in the left lung.

CT scan and AI Analysis

• Date: January 15, 2024

• Findings: A 0.8 cm lesion was detected in the upper left lung. The CT images were analyzed using an AI-powered diagnostic tool.

AI Results

• Date: January 16, 2024

• AI Prediction: The algorithm identified the lesion as suspicious for early-stage non-small cell lung cancer (NSCLC) with a confidence score of 94%.

Biopsy and Confirmation

• Date: January 20, 2024

• Findings: Biopsy confirmed early-stage NSCLC. Further tests indicated no metastasis, and surgery was recommended.

Follow-Up Consultation

• Date: January 25, 2024

• Plan: Discussed treatment options, including surgical removal of the tumor.

Diagnostic Assessment

AI-Powered Imaging Analysis

The objective imaging data of the patient's CT scans was fed through an AI algorithm used for the identification of lung cancer. The AI tool was trained on thousands of lung cancer cases making it to discern between benign and malignant lesions with a high level of accuracy. Here, based on the anatomical location and shape, the AI marked the lesion as potentially corresponding to NSCLC with a confidence of 94%, which suggested that the case should be referred for further analysis. The AI known as CNN was employed in the analysis of the shape, size, and texture of the lesion to discern patterns that conventional radiologists might not detect.

Traditional Diagnostic Methods

Moreover, the first X-ray and CT scan were reported by a radiologist and he pointed out the mass in the patient's lung as well. However, the radiologist was not conclusive with the malignancy report saying that since the size of the lesion is small and does not have an aggressive type of growth. A biopsy was taken to find out the type of the tumor, which they did, and found early-stage NSCLC.

Follow-Up and Outcomes

After receiving the biopsy results, the patient was referred to a thoracic surgeon for further examination. Given the cancer's early stage and the absence of metastases, the medical team recommended a lobectomy to remove the tumor. The operation was successful, and post-operative examinations, including imaging and blood testing, revealed no evidence of cancer recurrence.

Patient Outcome

The patient had a successful surgery, with clear margins suggesting that the tumor was completely removed. He was discharged from the hospital after a brief stay and urged to return for regular check-ups to watch for recurrence.

AI System Outcome

The AI system's forecast matched the final biopsy results, demonstrating its ability to help radiologists make more accurate diagnoses, particularly in spotting tiny, early-stage malignancies.

Discussion

The case also demonstrates the need to incorporate AI in the early triage of the disease. Other basic techniques such as X-rays, CT scans, or biopsies have become complemented with AI algorithms that detect early-stage lesions of cancer that may not be noticed or correctly interpreted by doctors. In this case, the AI model gave an accurate outcome of the existence of NSCLC and went further for further tests leading to an early diagnosis.

Many radiological diagnoses are subjective, but through the use of AI tools, clinicians can be empowered to diagnose cancers at an early stage when the disease is easily manageable. This is perhaps risky when it comes to lung cancer as it is often manageable if detected early enough. For example, the biochemical five-year survival rate of lung cancer for patients in the early stage is about 56%, while for those in the advanced stage, it is merely about 5%.

Furthermore, the characteristic of AI for its capacity to work through large amounts of data simultaneously enables the diagnosis algorithm to make these determinations much more quickly than a human and the time to treatment is likely to decrease which in the long run could decrease the costs of diagnosis and treatment. Over time, the possibility of AI being incorporated into general cancer check-ups reveals enhanced patient outcomes anticipating all types of cancer.

Takeaway

AI is set to transform cancer detection, as evidenced by this case of early-stage lung cancer. Healthcare professionals can enhance diagnosis accuracy, shorten treatment time, and eventually raise survival rates by utilizing machine learning models and deep learning algorithms. However, AI should be seen as a supplement rather than a substitute for trained radiologists and oncologists. The combination of human skills and AI technology has enormous potential for the future of cancer care.

Patient's Perspective

The patient expressed relief that the cancer had been found early, noting that the use of AI had accelerated the diagnostic process. Initially ignorant of the importance of AI in his diagnosis, the patient eventually recognized how technology had helped diagnose the disease at an early stage, while it was still curable. He remarked that the rapid turnaround time between his scan, biopsy, and surgery relieved some of the worry and anxiety he had during the procedure. The patient hopes that AI will continue to be used in healthcare to help others in similar situations.

Conclusion

Artificial intelligence is proving to be a great asset in cancer detection, as demonstrated by this case study of early-stage lung cancer. The AI system correctly recognized a small, worrisome lesion, resulting in timely care and a satisfactory patient outcome. While AI cannot replace human expertise, it is apparent that it may help with diagnostics and enhance accuracy. As AI advances, it is expected to play an increasingly important role in cancer care, resulting in earlier diagnoses, more effective therapies, and improved patient outcomes.

References

1. Ardila, D., Kiraly, A. P., Bharadwaj, S., et al. (2019). End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography. Nature Medicine, 25, 954–961.

2. Esteva, A., Kuprel, B., Novoa, R. A., et al. (2017). Dermatologist-level classification of skin cancer with deep neural networks. Nature, 542(7639), 115-118.

3. Hosny, A., Parmar, C., Quackenbush, J., Schwartz, L. H., & Aerts, H. J. (2018). Artificial intelligence in radiology. Nature Reviews Cancer, 18(8), 500-510.

4. McBee, M. P., Awan, O. A., Colucci, A. T., et al. (2018). Deep learning in radiology. Academic Radiology, 25(11), 1472-1480.

5. Siegel, R. L., Miller, K. D., & Jemal, A. (2020). Cancer statistics, 2020. CA: A Cancer Journal for Clinicians, 70(1), 7-30.

6. Xu, Y., Hosny, A., Zeleznik, R., et al. (2019). Deep learning predicts lung cancer treatment response from serial medical imaging. Clinical Cancer Research, 25(24), 7146-7154.

Read more such content on @ Hidoc Dr | Medical Learning App for Doctors